Concepedia

Thanos Mourikis

TM

Statistics

Publications

6

Citations

227

H-Index

6

Active since

2013

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

National and Kapodistrian University of Athens

Universidade dos Açores

University of Oxford

Thanos Mourikis is an author at Novartis (Switzerland) specializing in oncology, hippo signaling, and yap signaling.

ORCID

Publications per year

2013–2024

6

Publications

6

Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

Emilie A. Chapeau, Laurent Sansregret, Giorgio Giacomo Galli et al. · Nature Cancer · 2024 · 132 citations · Full text

, , +15

Abstract LB319: IAG933, a selective and orally efficacious YAP1/WWTR1(TAZ)-panTEAD protein-protein interaction inhibitor with pre-clinical activity in monotherapy and combinations

Tobias Schmelzle, Emilie A. Chapeau, Daniel Bauer et al. · Cancer Research · 2023 · 26 citations

, , +15

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants

Meriem Messaoudene, Thanos Mourikis, Judith Michels et al. · Annals of Oncology · 2019 · 25 citations · Full text

, , +17

Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens

Inês Amorim Monteiro Barbosa, Rajaraman Gopalakrishnan, Ş Mercan et al. · Nature Communications · 2023 · 20 citations · Full text

, , +17

Comparative phylogeography of endemic Azorean arthropods

Αristeidis Parmakelis, François Rigal, Thanos Mourikis et al. · BMC Evolutionary Biology · 2015 · 14 citations · Full text

, , +16

1–5 of 6